New cream for Pre-Cancerous skin spots enters first human safety trial
NCT ID NCT06888362
Summary
This was an early safety study of a new topical cream called GZ21T, intended to treat a common sun-damaged skin condition called actinic keratosis. The trial tested single applications of the cream on healthy volunteers to see how much gets absorbed into the body and to check for any skin reactions or other side effects. The main goal was to determine if the cream is safe enough to test further in people who actually have the skin condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACTINIC KERATOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CTC (Clinical Trial Consultants) AB
Uppsala, Sweden, 75237, Sweden
Conditions
Explore the condition pages connected to this study.